HOLX

NEUTRALM&A

Hologic, Inc.

2026-02-26

Price

$75.23

-0.15%

Score11.0Top Tier

Signals4/8 DNA2/13 Act · 0/4 Risk

SentimentNEUTRALScore: 0

Volume0.6xvs 20d avg

Analysis

The 'Steady Climb' and 'Alpha Male' signals are deceptive artifacts of a Merger Arbitrage peg, not organic growth momentum. HOLX is currently pinned to its acquisition price following the October 2025 agreement to be taken private by Blackstone and TPG for $76.00/share in cash plus a Contingent Value Right (CVR) of up to $3.00. The extremely low realized volatility (2.8%) confirms the stock is effectively waiting for the deal to close in 1H 2026. While the 'Risk On' regime favors high-beta tech, this asset serves as a 'High Score' cash-parking vehicle with a defined yield.

Fired Signals

ALPHA MALESTEADY CLIMBGOLDEN CROSSPERFECT STACKPANIC REVERSALBARGAIN HUNTER

Key Takeaways

**Merger Arb Thesis:** Long at $75.23 offers a ~1% gross spread to the $76.00 cash floor, plus a 'free' option on the $3.00 CVR (tied to future Breast Health revenue).
**Signal Distortion:** The 'Perfect Stack' and 'Steady Climb' indicators are false positives generated by the flat price action relative to a volatile broad market.
**Execution Risk:** The primary downside is regulatory blockage (FTC/DOJ); absent this, the price will drift slowly toward $76.00.

← Back to 2026-02-26 View Full HOLX History →Yahoo Finance &nearr;